Molecular basis of erythrocyte adhesion to endothelial cells in diseases

Clinical Hemorheology and Microcirculation

Volumn 53, Issue 1-2, 2013, Pages 11-21

  Wautier, Jean Luc ^a,b   Wautier, Marie Paule ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

adhesion molecules; diabetes; endothelial cell; malaria; polycythemia vera; Red blood cell; retinal vascular occlusion; sickle cell disease

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CELL RECEPTOR; ERYTHROCYTE MEMBRANE PROTEIN 1; HYDROXYUREA; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 4; PHOSPHATIDYLSERINE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ARTICLE; CELL ADHESION; CELL GROWTH; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ERYTHROCYTE; ERYTHROID CELL; ERYTHROID PRECURSOR CELL; HUMAN; MALARIA FALCIPARUM; POLYCYTHEMIA VERA; PROTEIN BINDING; PROTEIN EXPRESSION; SICKLE CELL; SICKLE CELL ANEMIA; VISUAL IMPAIRMENT;

ANEMIA, SICKLE CELL; ANIMALS; CELL ADHESION; CELL ADHESION MOLECULES; DIABETES MELLITUS; ERYTHROCYTES; HUMANS; HYDROXYUREA; MALARIA, FALCIPARUM; POLYCYTHEMIA VERA; PROTOZOAN PROTEINS; RECEPTORS, IMMUNOLOGIC; RETINAL VEIN OCCLUSION;

EID: 84872904099     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-2012-1572     Document Type: Article

References (62)

1. O. Arend, A. Remky, F. Jung, H. Kiesewetter,M. Reim and S.Wolf, Role of rheologic factors in patients with acute central retinal vein occlusion, Ophthalmology 103 (1996), 80-86.
2. L.A. Barber, M.B. Palascak, C.H. Joiner and R.S. Franco, Aminophospholipid translocase and phospholipid scramblase activities in sickle erythrocyte subpopulations, Br J Haematol 146 (2009), 447-455.
3. P. Bartolucci, V. Chaar, J. Picot, D. Bachir, A. Habibi, C. Fauroux, F. Galacteros, Y. Colin, C. Le Van Kim and W. El Nemer, Decreased sickle red blood cell adhesion to laminin by hydroxyurea is associated with inhibition of Lu/BCAM protein phosphorylation, Blood 116 (2010), 2152-2159.
4. E.J. Baxter, L.M. Scott, P.J. Campbell, C. East, N. Fourouclas, S. Swanton, G.S. Vassiliou, A.J. Bench, E.M. Boyd, N. Curtin, et al., Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders, Lancet 365 (2005), 1054-1061.
5. A.L. Bolcato-Bellemin, O. Lefebvre, C. Arnold, L. Sorokin, J.H. Miner, M. Kedinger and P. Simon-Assmann, Laminin alpha5 chain is required for intestinal smooth muscle development, Dev Biol 260 (2003), 376-390.
6. A. Chabanel, A. Glacet-Bernard, F. Lelong, A. Taccoen, G. Coscas and M.M. Samama, Increased red blood cell aggregation in retinal vein occlusion, Br J Haematol 75 (1990), 127-131.
7. S. Charache, M.L. Terrin, R.D. Moore, G.J. Dover, F.B. Barton, S.V. Eckert, R.P. McMahon and D.R. Bonds, Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia, N Engl J Med 332 (1995), 1317-1322.
8. Q. Chen, A. Heddini, A. Barragan, V. Fernandez, S.F. Pearce and M. Wahlgren, The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors, J Exp Med 192 (2000), 1-10.
9. V. De Stefano, A. Fiorini, E. Rossi, T. Za, G. Farina, P. Chiusolo, S. Sica and G. Leone, Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders, J Thromb Haemost 5 (2007), 708-714.
10. W. El Nemer, P. Gane, Y. Colin, V. Bony, C. Rahuel, F. Galacteros, J.P. Cartron and C. Le Van Kim, The Lutheran blood group glycoproteins, the erythroid receptors for laminin, are adhesion molecules, J Biol Chem 273 (1998), 16686-16693.
11. W. El Nemer, M.P. Wautier, C. Rahuel, P. Gane, P. Hermand, F. Galacteros, J.L. Wautier, J.P. Cartron, Y. Colin and C. Le Van Kim, Endothelial Lu/BCAM glycoproteins are novel ligands for red blood cell alpha4beta1 integrin: Role in adhesion of sickle red blood cells to endothelial cells, Blood 109 (2007), 3544-3551.
12. P.G. Gallagher, S.H. Chang, M.P. Rettig, J.E. Neely, C.A. Hillery, B.D. Smith and P.S. Low, Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis, Blood 101 (2003), 4625-4627.
13. E. Gauthier, C. Rahuel, M.P. Wautier, W. El Nemer, P. Gane, J.L. Wautier, J.P. Cartron, Y. Colin and C. Le Van Kim, Protein kinase A-dependent phosphorylation of Lutheran/basal cell adhesion molecule glycoprotein regulates cell adhesion to laminin alpha5, J Biol Chem 280 (2005), 30055-30062.
14. N. Grossin, M.P. Wautier, J. Picot, D.M. Stern and J.L. Wautier, Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms, Diabetes Metab 35 (2009), 410-417.
15. R. Hallmann, N. Horn, M. Selg, O. Wendler, F. Pausch and L.M. Sorokin, Expression and function of laminins in the embryonic and mature vasculature, Physiol Rev 85 (2005), 979-1000.
16. R.P. Hebbel, M.A. Boogaerts, J.W. Eaton and M.H. Steinberg, Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity, N Engl J Med 302 (1980), 992-995.
17. P. Hermand, P. Gane, I. Callebaut, N. Kieffer, J.P. Cartron and P. Bailly, Integrin receptor specificity for human red cell ICAM-4 ligand. Critical residues for alphaIIbeta3 binding, Eur J Biochem 271 (2004), 3729-3740.
18. E. Heron, C. Marzac, S. Feldman-Billard, J.F. Girmens, M. Paques, R. Delarue, J.C. Piette, N. Casadevall and O. Hermine, Endogenous erythroid colony formation in patients with retinal vein occlusion, Ophthalmology 114 (2007), 2155-2161.
19. P.C. Hines, Q. Zen, S.N. Burney, D.A. Shea, K.I. Ataga, E.P. Orringer, M.J. Telen and L.V. Parise, Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion, Blood 101 (2003), 3281-3287.
20. K.R. Hughes, G.A. Biagini and A.G. Craig, Continued cytoadherence of Plasmodium falciparum infected red blood cells after antimalarial treatment, Mol Biochem Parasitol 169 (2010), 71-78.
21. C. James, V. Ugo, J.P. Le Couedic, J. Staerk, F. Delhommeau, C. Lacout, L. Garcon, H. Raslova, R. Berger, A. Bennaceur-Griscelli, et al., A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera, Nature 434 (2005), 1144-1148.
22. M.C. Janssen, M. den Heijer, J.R. Cruysberg, H. Wollersheim and S.J. Bredie, Retinal vein occlusion: A form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors, Thromb Haemost 93 (2005), 1021-1026.
23. L. Joergensen, D.C. Bengtsson, A. Bengtsson, E. Ronander, S.S. Berger, L. Turner, M.B. Dalgaard, G.K. Cham, M.E.Victor, T. Lavstsen, et al., Surface co-expression of two different PfEMP1 antigens on single plasmodium falciparum-infected erythrocytes facilitates binding to ICAM1 and PECAM1, PLoS Pathog 6 (2010), e1001083.
24. F.A. Kuypers, J. Yuan, R.A. Lewis, L.M. Snyder, C.R. Kiefer, A. Bunyaratvej, S. Fucharoen, L. Ma, L. Styles, K. de Jong and S.L. Schrier, Membrane phospholipid asymmetry in human thalassemia, Blood 91 (1998), 3044-3051.
25. T. Lavstsen, A. Salanti, A.T. Jensen, D.E. Arnot and T.G. Theander, Sub-grouping of Plasmodium falciparum 3D7 var genes based on sequence analysis of coding and non-coding regions, Malar J 2 (2003), 27.
26. K. Lee, P. Gane, F. Roudot-Thoraval, B. Godeau, D. Bachir, F. Bernaudin, J.P. Cartron, F. Galacteros and P. Bierling, The nonexpression of CD36 on reticulocytes and mature red blood cells does not modify the clinical course of patients with sickle cell anemia, Blood 98 (2001), 966-971.
27. P. Lim, C. Wongsrichanalai, P. Chim, N. Khim, S. Kim, S. Chy, R. Sem, S. Nhem, P. Yi, S. Duong, et al., Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007, Antimicrob Agents Chemother 54 (2010), 2135-2142.
28. A.G. Maier, B.M. Cooke, A.F. Cowman and L. Tilley, Malaria parasite proteins that remodel the host erythrocyte, Nat Rev Microbiol 7 (2009), 341-354.
29. R. Marcucci, L. Bertini, B. Giusti, T. Brunelli, S. Fedi, A.P. Cellai, D. Poli, G. Pepe, R. Abbate and D. Prisco, Thrombophilic risk factors in patients with central retinal vein occlusion, Thromb Haemost 86 (2001), 772-776.
30. L.H. Miller, M.F. Good and G. Milon, Malaria pathogenesis, Science 264 (1994), 1878-1883.
31. S.F. Parsons, G. Lee, F.A. Spring, T.N. Willig, L.L. Peters, J.A. Gimm, M.J. Tanner, N. Mohandas, D.J. Anstee and J.A. Chasis, Lutheran blood group glycoprotein and its newly characterized mouse homologue specifically bind alpha5 chain-containing human laminin with high affinity, Blood 97 (2001), 312-320.
32. J.T. Prchal, Polycythemia vera and other primary polycythemias, Curr Opin Hematol 12 (2005), 112-116.
33. M. Rehak, P. Wiedemann, Retinal vein thrombosis: Pathogenesis and management, J Thromb Haemost 8 (2010), 1886-1894.
34. B.A. Robinson, T.L. Welch and J.D. Smith, Widespread functional specialization of Plasmodium falciparum erythrocyte membrane protein 1 family members to bindCD36analysed across a parasite genome, Mol Microbiol 47 (2003), 1265-1278.
35. S.L. Rogers, R.L. McIntosh, L. Lim, P. Mitchell, N. Cheung, J.W.Kowalski, H.P. Nguyen, J.J.Wang and T.Y.Wong, Natural history of branch retinal vein occlusion: An evidence-based systematic review, Ophthalmology 117 (2010), 1094-1101 e1095.
36. L.M. Scott, W. Tong, R.L. Levine, M.A. Scott, P.A. Beer, M.R. Stratton, P.A. Futreal, W.N. Erber, M.F. McMullin, C.N. Harrison, et al., JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis, N Engl J Med 356 (2007), 459-468.
37. F. Sofi, L. Mannini, R. Marcucci, P. Bolli, A. Sodi, B. Giambene, U. Menchini, G.F. Gensini, R. Abbate and D. Prisco, Role of haemorheological factors in patients with retinal vein occlusion, Thromb Haemost 98 (2007), 1215-1219.
38. E. Soupene and F.A. Kuypers, Identification of an erythroid ATP-dependent aminophospholipid transporter, Br J Haematol 133 (2006), 436-438.
39. M.J. Southcott, M.J. Tanner and D.J. Anstee, The expression of human blood group antigens during erythropoiesis in a cell culture system, Blood 93 (1999), 4425-4435.
40. R.D. Sperduto, R. Hiller, E. Chew, D. Seigel, N. Blair, T.C. Burton, M.D. Farber, E.S. Gragoudas, J. Haller, J.M. Seddon and L.A. Yannuzzi, Risk factors for hemiretinal vein occlusion: Comparison with risk factors for central and branch retinal vein occlusion: The eye disease case-control study, Ophthalmology 105 (1998), 765-771.
41. K. Sugihara, T. Sugihara, N. Mohandas and R.P. Hebbel, Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells, Blood 80 (1992), 2634-2642.
42. R. Tamarat, J.S. Silvestre, M. Huijberts, J. Benessiano, T.G. Ebrahimian, M. Duriez, M.P. Wautier, J.L. Wautier and B.I. Levy, Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice, Proc Natl Acad Sci U S A 100 (2003), 8555-8560.
43. C.J. Treutiger, A. Heddini, V. Fernandez, W.A. Muller and M. Wahlgren, PECAM-1/CD31, an endothelial receptor for binding Plasmodium falciparum-infected erythrocytes, Nat Med 3 (1997), 1405-1408.
44. M. Udani, Q. Zen, M. Cottman, N. Leonard, S. Jefferson, C. Daymont, G. Truskey and M.J. Telen, Basal cell adhesion molecule/lutheran protein. The receptor critical for sickle cell adhesion to laminin, J Clin Invest 101 (1998), 2550-2558.
45. N. Vainionpaa, Y. Kikkawa, K. Lounatmaa, J.H. Miner, P. Rousselle and I. Virtanen, Laminin-10 and Lutheran blood group glycoproteins in adhesion of human endothelial cells, Am J Physiol Cell Physiol 290 (2006), C764-C775.
46. J.L. Wautier, F. Galacteros, M.P. Wautier, D. Pintigny, Y. Beuzard, J. Rosa and J.P. Caen, Clinical manifestations and erythrocyte adhesion to endothelium in sickle cell syndrome, Am J Hematol 19 (1985), 121-130.
47. J.L. Wautier, H. LeBlanc, M.P. Wautier, E. Abadie, P. Passa and J.P. Caen, Erythrocyte adhesion to cultured endothelium and glycaemic control in type 1 (insulin-dependent) diabetic patients, Diabetologia 29 (1986), 151-155.
48. J.L. Wautier, R.C. Paton, M.P. Wautier, D. Pintigny, E. Abadie, P. Passa and J.P. Caen, Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications, N Engl J Med 305 (1981), 237-242.
49. J.L. Wautier, D. Pintigny, M.P. Wautier, R.C. Paton, F. Galacteros, P. Passa and J.P. Caen, Fibrinogen, a modulator of erythrocyte adhesion to vascular endothelium, J Lab Clin Med 101 (1983), 911-920.
50. J.L.Wautier and A.M. Schmidt, Protein glycation: A firm link to endothelial cell dysfunction, Circ Res 95 (2004), 233-238.
51. J.L. Wautier, M.P. Wautier, A.M. Schmidt, G.M. Anderson, O. Hori, C. Zoukourian, L. Capron, O. Chappey, S.D. Yan, J. Brett, et al., Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: A link between surface-associated AGEs and diabetic complications, Proc Natl Acad Sci U S A 91 (1994), 7742-7746.
52. J.L. Wautier, C. Zoukourian, O. Chappey, M.P. Wautier, P.J. Guillausseau, R. Cao, O. Hori, D. Stern and A.M. Schmidt, Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats, J Clin Invest 97 (1996), 238-243.
53. M.P. Wautier, E. Boulanger, P.J. Guillausseau, P. Massin and J.L. Wautier, AGEs, macrophage colony stimulating factor and vascular adhesion molecule blood levels are increased in patients with diabetic microangiopathy, Thromb Haemost 91 (2004), 879-885.
54. M.P. Wautier, O. Chappey, S. Corda, D.M. Stern, A.M. Schmidt and J.L. Wautier, Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE, Am J Physiol Endocrinol Metab 280 (2001), E685-E694.
55. M.P.Wautier,W. El Nemer, P. Gane, J.D. Rain, J.P. Cartron,Y. Colin, C. LeVan Kim and J.L.Wautier, Increased adhesion to endothelial cells of erythrocytes from patients with polycythemia vera is mediated by laminin alpha5 chain and Lu/BCAM, Blood 110 (2007), 894-901.
56. M.P. Wautier, E. Heron, J. Picot, Y. Colin, O. Hermine and J.L. Wautier, Red blood cell phosphatidylserine exposure is responsible for increased erythrocyte adhesion to endothelium in central retinal vein occlusion, J Thromb Haemost 9 (2011), 1049-1055.
57. M.P.Wautier, T. Khodabandehlou, C. Le Devehat and J.L.Wautier, Modulation ofRAGEexpression influences the adhesion of red blood cells from diabetic patients, Clin Hemorheol Microcirc 35 (2006), 379-386.
58. T.H. Williamson, Central retinal vein occlusion: What's the story? Br J Ophthalmol 81 (1997), 698-704.
59. J.L. Wolfs, P. Comfurius, J.T. Rasmussen, J.F. Keuren, T. Lindhout, R.F. Zwaal and E.M. Bevers, Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserine exposure in a distinct platelet fraction, Cell Mol Life Sci 62 (2005), 1514-1525.
60. B.L. Wood, D.F. Gibson and J.F. Tait, Increased erythrocyte phosphatidylserine exposure in sickle cell disease: Flowcytometric measurement and clinical associations, Blood 88 (1996), 1873-1880.
61. M. Yasuda, Y. Kiyohara, S. Arakawa, Y. Hata, K. Yonemoto, Y. Doi, M. Iida and T. Ishibashi, Prevalence and systemic risk factors for retinal vein occlusion in a general Japanese population: The Hisayama study, Invest Ophthalmol Vis Sci 51 (2010), 3205-3209.
62. S. Yedgar, D.K. Kaul and G. Barshtein, RBC adhesion to vascular endothelial cells: More potent than RBC aggregation in inducing circulatory disorders, Microcirculation 15 (2008), 581-583.